By Counterforce Health Team in Acthar Gel (repository corticotropin injection) —

Do You Qualify for Acthar Gel Coverage by Aetna CVS Health in Texas? Decision Tree & Next Steps

Answer Box: Acthar Gel Coverage by Aetna CVS Health in Texas

Yes, you can get Acthar Gel covered by Aetna CVS Health in Texas, but prior authorization is required for all uses. Your best path to approval:

  1. Confirm eligibility: Infantile spasms (under 24 months) or MS exacerbations after steroid failure have the highest approval rates
  2. Submit complete PA: Use Aetna's Statement of Medical Necessity form with diagnosis confirmation, prior therapy records, and specialist letter
  3. Call CVS Specialty: 866-752-7021 for urgent cases or status updates

Timeline: 14 business days standard, 72 hours expedited. If denied, Texas law guarantees external review within 30 days.

Table of Contents

How to Use This Decision Tree

This guide helps you determine your likelihood of getting Acthar Gel (repository corticotropin injection) covered by Aetna CVS Health in Texas. We'll walk through the key eligibility factors, required documentation, and next steps based on your specific situation.

Before you start, gather these documents:

  • Insurance card and policy details
  • Complete medical records for your condition
  • Documentation of any previous treatments tried
  • Recent lab results, imaging, or EEG reports (if applicable)
  • List of current medications

Eligibility Triage: Do You Qualify?

Likely Eligible ✅

Infantile Spasms (West Syndrome)

  • Child under 24 months old
  • Confirmed diagnosis with EEG showing hypsarrhythmia
  • Documented spasms with video or clinical observation
  • Pediatric neurologist involvement

MS Exacerbations

  • Confirmed multiple sclerosis diagnosis
  • Acute relapse with functional impairment
  • Failed high-dose corticosteroids OR documented contraindication
  • Neurologist supporting Acthar use

Possibly Eligible ⚠️

Other FDA-Labeled Conditions

  • Rheumatologic conditions (RA, lupus, dermatomyositis)
  • Nephrotic syndrome
  • Optic neuritis
  • Sarcoidosis

Requirements for approval:

  • Extensive prior therapy failures documented
  • Specialist letter explaining why Acthar is necessary
  • Objective measures showing disease activity

Not Yet Eligible ❌

Missing Requirements

  • No documented trials of standard therapies
  • Insufficient specialist involvement
  • Lacking objective diagnostic confirmation
  • Using for off-label/experimental purposes

If "Likely Eligible": Your Action Plan

Step 1: Gather Required Documentation (2-3 days)

For Infantile Spasms:

  • Recent EEG results showing spasm patterns
  • Video documentation of spasms (if available)
  • Pediatric neurology consultation notes
  • Growth and development assessments

For MS Exacerbations:

  • MRI results showing active lesions
  • Neurological examination findings
  • Documentation of steroid trial failure (drug, dose, duration, outcome)
  • Functional disability scores (EDSS if available)

Step 2: Complete Aetna's Statement of Medical Necessity (1-2 days)

Contact your prescriber to complete Aetna's PA form including:

  • ICD-10 diagnosis codes
  • Proposed dosing and duration
  • Clinical rationale for Acthar vs. alternatives
  • Prior therapy history

Step 3: Submit to CVS Specialty Pharmacy

Standard submission:

  • Fax: 888-267-3277
  • Phone: 866-752-7021
  • Online: CVS provider portal

Expedited submission (for urgent cases):

  • Call 866-752-7021 directly
  • Document medical urgency in cover letter
  • Request 72-hour review

Step 4: Follow Up and Track Progress

  • Standard review: 14 business days
  • Expedited review: 72 hours
  • Call for status updates if no response within expected timeframe

If "Possibly Eligible": Tests to Request

Additional Documentation Needed

Objective Disease Measures:

  • Laboratory markers of inflammation (ESR, CRP, complement levels)
  • Disease-specific tests (anti-dsDNA for lupus, RF/anti-CCP for RA)
  • Imaging studies showing active disease
  • Pulmonary function tests (for sarcoidosis)

Prior Therapy Documentation:

  • Pharmacy records showing filled prescriptions
  • Clinical notes documenting response to each treatment
  • Adverse event reports for intolerances
  • Dosing and duration details for each trial

Timeline to Reapply

Once you have comprehensive documentation:

  • Compile records: 1-2 weeks
  • Specialist consultation: 2-4 weeks
  • PA submission and review: 2-6 weeks total

If "Not Yet": Alternative Options

First-Line Therapies to Try

For MS Exacerbations:

  • High-dose IV methylprednisolone (500-1000 mg daily × 3-7 days)
  • Oral prednisone with taper (if IV contraindicated)

For Rheumatologic Conditions:

  • Methotrexate + corticosteroids
  • Biologics (TNF inhibitors, rituximab)
  • IVIG for refractory cases

Preparing for Future Exception Requests

Document everything:

  • Response to each treatment (objective measures)
  • Adverse effects experienced
  • Reasons for discontinuation
  • Specialist recommendations for next steps

If Denied: Texas Appeal Process

Internal Appeal (First Level)

Timeline: Must file within 180 days of denial Review time: 45 days standard, 72 hours expedited How to file:

  • Online: Aetna member portal
  • Phone: Member services number on insurance card
  • Mail: Address provided in denial letter

Required documents:

  • Completed appeal form
  • Updated medical records
  • Specialist letter addressing denial reasons
  • Peer-reviewed literature supporting use

External Review (Texas IRO)

If internal appeal fails, Texas law provides binding external review through an Independent Review Organization (IRO).

Eligibility:

  • Denial based on medical necessity or experimental/investigational designation
  • Cost exceeds $500 (typically met for Acthar)

Timeline:

  • File within 4 months of final denial
  • Standard review: 30 days
  • Expedited review: 72 hours for urgent cases

Contact: Texas Department of Insurance IRO line: 1-866-554-4926

Note: For ERISA self-funded employer plans, federal external review rules apply instead of Texas state law.

Coverage Requirements at a Glance

Requirement Details Documentation Needed Source
Prior Authorization Required for all uses Complete PA form Aetna Policy
Formulary Status Tier 4/5 specialty CVS Specialty dispensing only CVS Specialty Drug List
Step Therapy Required (except infantile spasms) Corticosteroid failure records Aetna Clinical Policy
Specialist Required Condition-specific Neurology, rheumatology, nephrology PA Requirements
Age Restrictions <24 months for infantile spasms Birth certificate, medical records FDA Labeling

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Evidence
"Not medically necessary" Provide objective disease measures and specialist rationale Recent labs, imaging, EEG; specialist letter citing guidelines
"Step therapy not met" Document adequate corticosteroid trials Pharmacy records, clinical notes showing doses/duration/outcomes
"Alternative therapies available" Show contraindications or failures of alternatives Adverse event documentation, allergy records, ineffectiveness notes
"Experimental/investigational" Cite FDA labeling and published guidelines FDA package insert, specialty society recommendations
"Quantity/dosing exceeded" Justify weight-based or condition-specific dosing Clinical calculations, dosing rationale, monitoring plan

Clinician Corner: Medical Necessity Letter Essentials

Healthcare providers should include these key elements in the medical necessity letter:

Clinical Rationale:

  • Specific diagnosis with ICD-10 codes
  • Objective measures of disease severity
  • Functional impairment documentation
  • Treatment goals and expected outcomes

Prior Therapy Documentation:

  • Chronological list of treatments tried
  • Specific drugs, doses, and durations
  • Response to each therapy (objective measures)
  • Reasons for discontinuation or failure

Literature Support:

  • FDA labeling for indication
  • Relevant clinical guidelines
  • Peer-reviewed studies (if applicable)
  • Comparison to alternative therapies

When dealing with insurance coverage challenges, many families and healthcare providers turn to specialized services like Counterforce Health for assistance with prior authorization appeals. These platforms help translate complex clinical information into the specific documentation format that insurers require, potentially improving approval rates and reducing delays in care.

FAQ

How long does Aetna CVS Health prior authorization take in Texas? Standard PA review takes 14 business days. Expedited review for urgent cases is completed within 72 hours. You can request expedited review if delays would jeopardize your health.

What if Acthar Gel is not on my formulary? You can request a formulary exception through Aetna's PA process. Provide documentation that covered alternatives are inappropriate or have failed, along with a specialist letter supporting Acthar use.

Can I appeal if I'm on a self-funded employer plan? Yes, but ERISA self-funded plans follow federal appeal rules rather than Texas state law. You still have internal and external review rights, but timelines and processes may differ.

Does step therapy apply if I tried corticosteroids in another state? Yes, prior therapy documentation from any provider/state counts toward step therapy requirements. Ensure you have complete pharmacy records and clinical notes from the treating physician.

What if I can't afford Acthar Gel even with insurance coverage? Mallinckrodt offers copay assistance up to $15,000 annually for eligible patients. Visit Acthar Patient Support to apply. Additional foundation grants may be available for qualifying conditions.

How do I request an expedited appeal in Texas? Contact Aetna member services and request expedited review, providing documentation that delays would jeopardize your health. For external review, call the Texas Department of Insurance IRO line at 1-866-554-4926.

From Our Advocates

"We've seen families successfully obtain Acthar coverage for infantile spasms even after initial denials by providing comprehensive EEG documentation and pediatric neurology letters that clearly explain why immediate treatment is critical for developmental outcomes. The key is often getting the specialist to address the insurer's specific concerns about timing and alternatives in their letter, rather than just stating medical necessity."

Sources & Further Reading

For additional assistance with complex prior authorization cases, Counterforce Health specializes in turning insurance denials into successful appeals through evidence-based documentation and payer-specific strategies.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances, plan details, and medical necessity. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For official Texas insurance regulations and appeal processes, contact the Texas Department of Insurance at 1-800-252-3439.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.